Considering the potential impact of the present findings, enhanced characterization of HCMV-driven CD8+ T cell responses and their relationships with clinical features in a larger cohort of SSc patients will lead to a deeper understanding of the pathogenesis of this autoimmune disease and also to better patient management and new therapeutic approaches. This evidence concerns the gene CD8A and autoimmune disease.